SCPHARMACEUTICALS INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 46 rows in 2025. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2025-10-07: Reporting owner SCHAEFFER LEONARD D; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2025-10-07: Reporting owner SCHAEFFER LEONARD D; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2025-10-07: Reporting owner SCHAEFFER LEONARD D; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2025-10-07: Reporting owner VEITINGER KLAUS R DR; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-10-07 | SCHAEFFER LEONARD D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $3.85 exercise price | 2025-10-07 | |
| 2025-10-07 | SCHAEFFER LEONARD D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,750 0 owned after | $4.11 exercise price | 2025-10-07 | |
| 2025-10-07 | SCHAEFFER LEONARD D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,300 0 owned after | $4.53 exercise price | 2025-10-07 | |
| 2025-10-07 | VEITINGER KLAUS R DR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $3.85 exercise price | 2025-10-07 | |
| 2025-10-07 | VEITINGER KLAUS R DR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,750 0 owned after | $4.11 exercise price | 2025-10-07 | |
| 2025-10-07 | VEITINGER KLAUS R DR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,300 0 owned after | $4.53 exercise price | 2025-10-07 | |
| 2025-10-07 | VEITINGER KLAUS R DR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,124 0 owned after | $3.37 exercise price | 2025-10-07 | |
| 2025-10-07 | Abraham William Tober Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $3.85 exercise price | 2025-10-07 | |
| 2025-10-07 | Abraham William Tober Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,750 0 owned after | $4.11 exercise price | 2025-10-07 | |
| 2025-10-07 | Abraham William Tober Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,300 0 owned after | $4.53 exercise price | 2025-10-07 | |
| 2025-10-07 | Baylor-Henry Minnie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $3.85 exercise price | 2025-10-07 | |
| 2025-10-07 | Baylor-Henry Minnie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,750 0 owned after | $4.11 exercise price | 2025-10-07 | |
| 2025-10-07 | Baylor-Henry Minnie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,300 0 owned after | $4.53 exercise price | 2025-10-07 | |
| 2025-10-07 | Baylor-Henry Minnie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,124 0 owned after | $3.37 exercise price | 2025-10-07 | |
| 2025-10-07 | Baylor-Henry Minnie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,248 0 owned after | $4.80 exercise price | 2025-10-07 | |
| 2025-10-07 | Hudson Frederick M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $3.85 exercise price | 2025-10-07 | |
| 2025-10-07 | Hudson Frederick M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,750 0 owned after | $4.11 exercise price | 2025-10-07 | |
| 2025-10-07 | Hudson Frederick M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,300 0 owned after | $4.53 exercise price | 2025-10-07 | |
| 2025-10-07 | Hudson Frederick M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,124 0 owned after | $3.37 exercise price | 2025-10-07 | |
| 2025-10-07 | Nokes Rachael Officer (CFO and Treasurer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −132,670 0 owned after | $3.34 exercise price | 2025-10-07 | |
| 2025-10-07 | Nokes Rachael Officer (CFO and Treasurer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −54,700 0 owned after | $4.31 exercise price | 2025-10-07 | |
| 2025-10-07 | Nokes Rachael Officer (CFO and Treasurer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,426 0 owned after | $3.81 exercise price | 2025-10-07 | |
| 2025-10-07 | Nokes Rachael Officer (CFO and Treasurer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −13,850 0 owned after | $4.88 exercise price | 2025-10-07 | |
| 2025-10-07 | Tucker John H Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −300,000 0 owned after | $3.34 exercise price | 2025-10-07 | |
| 2025-10-07 | Tucker John H Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −84,500 0 owned after | $3.25 exercise price | 2025-10-07 | |
| 2025-10-07 | Tucker John H Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −249,000 0 owned after | $4.31 exercise price | 2025-10-07 | |
| 2025-10-07 | Tucker John H Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −496,674 0 owned after | $3.81 exercise price | 2025-10-07 | |
| 2025-10-07 | Agger Mette Kirstine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $3.85 exercise price | 2025-10-07 | |
| 2025-10-07 | Agger Mette Kirstine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,750 0 owned after | $4.11 exercise price | 2025-10-07 | |
| 2025-10-07 | Bonstein Sara Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $3.85 exercise price | 2025-10-07 | |
| 2025-10-07 | Bonstein Sara Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,750 0 owned after | $4.11 exercise price | 2025-10-07 | |
| 2025-10-07 | Bonstein Sara Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,300 0 owned after | $4.53 exercise price | 2025-10-07 | |
| 2025-10-07 | Khattar Jack A. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $3.85 exercise price | 2025-10-07 | |
| 2025-10-07 | Khattar Jack A. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,750 0 owned after | $4.11 exercise price | 2025-10-07 | |
| 2025-10-07 | Khattar Jack A. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,300 0 owned after | $4.53 exercise price | 2025-10-07 | |
| 2025-10-07 | Khattar Jack A. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,124 0 owned after | $3.37 exercise price | 2025-10-07 | |
| 2025-06-03 | Agger Mette Kirstine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.85 exercise price | 2025-06-05 | |
| 2025-06-03 | Baylor-Henry Minnie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.85 exercise price | 2025-06-05 | |
| 2025-06-03 | Bonstein Sara Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.85 exercise price | 2025-06-05 | |
| 2025-06-03 | Hudson Frederick M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.85 exercise price | 2025-06-05 | |
| 2025-06-03 | Khattar Jack A. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.85 exercise price | 2025-06-05 | |
| 2025-06-03 | VEITINGER KLAUS R DR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.85 exercise price | 2025-06-05 | |
| 2025-06-03 | Abraham William Tober Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.85 exercise price | 2025-06-05 | |
| 2025-06-03 | SCHAEFFER LEONARD D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $3.85 exercise price | 2025-06-05 | |
| 2025-02-11 | Tucker John H Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $3.34 exercise price | 2025-02-12 | |
| 2025-02-11 | Nokes Rachael Officer (CFO and Treasurer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +132,670 132,670 owned after | $3.34 exercise price | 2025-02-12 |